Validation of a Screening Tool in Geriatric Oncology
OBJECTIVES:
Primary
- Validate a new screening tool (G8).
Secondary
- Validate the French version of the screening tool "Vulnerable Elders Survey (VES-13)".
- Evaluate the merits of the screening tools (G8 and VES-13).
- Assess the screening tool in specific populations.
- Assess the number and type of interventions proposed after thorough geriatric
assessment.
- Compare the two new tools (G8 vs VES-13).
OUTLINE: This is a multicenter study.
During the first consultation, patients have an initial clinical evaluation questionnaire
comprising the G8. They also complete the self-questionnaire VES-13. Within 30 days,
patients have a thorough geriatric assessment, including quality of life and physical
function, by a physician without access to the G8 or VES-13 questionnaires. A blood specimen
is also collected.
Information on health status and quality of life is collected from medical records or from
the doctor after 1 and 5 years.
Interventional
Allocation: Non-Randomized, Masking: Open Label, Primary Purpose: Screening
Validation of G8 screening tool
No
Pierre Soubeyran, MD, PhD
Principal Investigator
Institut BergoniƩ
United States: Federal Government
CDR0000637122
NCT00963911
June 2008
Name | Location |
---|